Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2014
10/02/2014US20140298515 Soybean cultivar wn1115965
10/02/2014US20140298514 Soybean cultivar wn1118516
10/02/2014US20140298513 Soybean cultivar wn1118509
10/02/2014US20140298512 Soybean cultivar go1110272
10/02/2014US20140298510 Manipulation of dominant male sterility
10/02/2014US20140298509 Vegetabile material, plants and a method of producing a plant having altered lignin properties
10/02/2014US20140298506 Melon hybrid sv0331mv and parents thereof
10/02/2014US20140298502 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
10/02/2014US20140298501 Modified arthropod and method of use
10/02/2014US20140298496 Phenocopy model of disease
10/02/2014US20140298494 Animal model of autism
10/02/2014US20140298493 PIK3CA H1047R Knock-In Non-Human Animal Breast Cancer Model
10/02/2014US20140296505 Compositions and methods for bacterial production of chondroitin
10/02/2014US20140296504 Hepatitis b viral variants with reduced susceptibility to nucleoside analogs and uses thereof
10/02/2014US20140296503 ISOLATED dsRNA MOLECULES AND METHODS OF USING SAME FOR SILENCING TARGET MOLECULES OF INTEREST
10/02/2014US20140296502 Antisense design
10/02/2014US20140296500 Methods and Compositions of Nucleic Acid Ligands for Detection of Clinical Analytes Related to Human Health
10/02/2014US20140296497 Method for Producing Myo-Inositol and Myo-Inositol Derivative
10/02/2014US20140296494 Protein expression in plants
10/02/2014US20140296324 Vectors harboring toxic genes, methods and uses therefor
10/02/2014US20140296323 Tricyclo-phosphorothioate dna
10/02/2014US20140296322 Conjugates, particles, compositions, and related methods of use
10/02/2014US20140296321 Methods and compositions for manipulating translation of protein isoforms from alternative initiation of start sites
10/02/2014US20140296320 Use Of siRNA To Achieve Down Regulation Of An Endogenous Gene In Combination With The Use of A Sense Construct To Achieve Expression Of A Polynucleotide
10/02/2014US20140296319 Composition For Promoting Apoptosis Or Inhibiting Cell Growth, Comprising Epstein-Barr Virus Microrna
10/02/2014US20140296318 Novel tissue protective erythropoietin receptor (nepor) and methods of use
10/02/2014US20140296218 Super-enhancers and methods of use thereof
10/02/2014US20140296138 Methods and compositions for controlling nematode pests
10/02/2014US20140296111 Protein-Immobilizing Solid Phase, Polynucleotide-Immobilizing Solid Phase, and Nucleic Acid Recovery Method
10/02/2014US20140296102 Nucleic Acid Ligand Diagnostic Biochip
10/02/2014US20140296093 Use of multiple recombination sites with unique specificity in combinational cloning
10/02/2014US20140296090 Assay methods for increased throughput of samples and/or targets
10/02/2014US20140295558 Method and apparatus for delivery of molecules to cells
10/02/2014US20140295557 Using Truncated Guide RNAs (tru-gRNAs) to Increase Specificity for RNA-Guided Genome Editing
10/02/2014US20140295556 Using RNA-guided FokI Nucleases (RFNs) to Increase Specificity for RNA-Guided Genome Editing
10/02/2014US20140295543 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
10/02/2014US20140295540 Means for generating adenoviral vectors for cloning large nucleic acids
10/02/2014US20140295514 Fermentative glycerol-free ethanol production
10/02/2014US20140295510 Eukaryotic cell and method for producing glycolic acid
10/02/2014US20140295503 Methods and devices for biological sample preparation
10/02/2014US20140295502 cDNA Synthesis Improvements
10/02/2014US20140295501 Novel method to load a mammalian artificial chromosome with multiple genes
10/02/2014US20140295497 Vectors and host cells comprising a modified sv40 promoter for protein expression
10/02/2014US20140295489 Organic compounds
10/02/2014US20140295457 Gene cluster for biosynthesis of griselimycin and methylgriselimycin
10/02/2014US20140295448 SUPPRESSION OF TLA2-CpFTSY GENE EXPRESSION FOR IMPROVED SOLAR ENERGY CONVERSION EFFICIENCY AND PHOTOSYNTHETIC PRODUCTIVITY IN ALGAE
10/02/2014US20140295436 Methods for Multiplexing Recombinase Polymerase Amplification
10/02/2014US20140295411 Methods and reagents for preserving rna in cell and tissue samples
10/02/2014US20140295409 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
10/02/2014US20140294943 Methods of using microrna 195 in providing neuroprotection
10/02/2014US20140294939 Pulmonary delivery of mrna
10/02/2014US20140294938 Mrna therapy for fabry disease
10/02/2014US20140294936 Compositions And Methods For Inhibiting Expression Of The HAMP Gene
10/02/2014US20140294935 Vaccine composition
10/02/2014US20140294934 Cationic lipids for therapeutic agent delivery formulations
10/02/2014US20140294929 Compositions for delivery of cargo such as drugs proteins and/or genetic materials
10/02/2014US20140294927 Synthetic nanostructures including nucleic acids and/or other entities
10/02/2014US20140294895 Expression of Protective Antigens in Transgenic Chloroplasts and the Production of Improved Vaccines
10/02/2014US20140294893 Recombinant nonpathogenic mdv vector providing multivalent immunity
10/02/2014US20140294892 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus
10/02/2014US20140294891 Microorganisms for therapy
10/02/2014US20140294886 Isolated protein and compositions comprising the protein
10/02/2014US20140294885 Heterologous expression of neisserial proteins
10/02/2014US20140294884 Meningococcus adhesins nada, app and orf 40
10/02/2014US20140294881 Proteases producing an altered immunological response and methods of making and using the same
10/02/2014US20140294869 Immune tolerance inducer
10/02/2014US20140294862 Methods of modulating the negative chemotaxis of immune cells
10/02/2014US20140294860 Means and methods for treating and/or preventing natural ahr ligand-dependent cancer
10/02/2014US20140294857 Methods of obtaining a specific binding member that binds eotaxin
10/02/2014US20140294854 Target directed to adipocytes, methods and assays for treatment of obesity
10/02/2014US20140294842 Assays, Methods and Means
10/02/2014US20140294840 Expression of mirnas in placental tissue
10/02/2014US20140294820 Fibroblast growth factor receptor inhibition for the treatment of disease
10/02/2014US20140294816 Combination therapy for the treatment of ocular neovascular disorders
10/02/2014US20140294793 Gpr15-mediated homing and uses thereof
10/02/2014US20140294785 Dosage compensating transgenes and cells
10/02/2014US20140294773 Modified cascade ribonucleoproteins and uses thereof
10/02/2014US20140294771 Adeno-Associated Virus Virions with Variant Capsid and Methods of Use Thereof
10/02/2014US20140294760 Novel cell and therapeutical and diagnostical methods based thereon
10/02/2014US20140291576 Isolation of nucleic acid
10/02/2014DE102013205660A1 Anordnung und Verfahren zum Anreichern einer Nukleinsäure mit Hilfe der Feld-Fluss-Fraktionierung Arrangement and method for enriching a nucleic acid with the aid of the field-flow fractionation
10/02/2014DE102013009744A1 Fusionsmischung zur lipidhaltigen Membranmodifikation einer beliebigen Lipidmembran, einer Zellmembran, einem Bestandteil einer Zellmembran oder einer von den übrigen Zell- Bestandteilen getrennten Zellmembran in vivo oder in vitro Fusion mixture for lipid-containing membrane of any modification of the lipid membrane, a cell membrane, a component of a cell membrane or a position separated from the other cell components in vivo or in vitro cell membrane
10/02/2014DE102013005361A1 Polyribonucleotid Polyribonucleotide
10/02/2014DE102013005154A1 Verfahren zum Einbau von lysosomalen Transmembranproteinen in zelluläre Membranen A method for incorporation of transmembrane proteins into cellular lysosomal membranes
10/02/2014CA2847899A1 Mixture composition comprising rhamnolipids
10/01/2014EP2784162A1 Engineering of systems, methods and optimized guide compositions for sequence manipulation
10/01/2014EP2784161A1 Mutant xylanase, manufacturing method and use therefor, and method for manufacturing saccharified lignocellulose
10/01/2014EP2784160A1 Novel gene derived from mud flat metagenome and novel protein obtained therefrom showing coactivity of phospholipase and lipase
10/01/2014EP2784159A1 Hepatitis b virus-derived cis-regulatory element and use thereof
10/01/2014EP2784158A1 Plant transforment, transformation method for plant, and vector used in said method
10/01/2014EP2784157A1 Design method for rna-binding protein using ppr motif, and use thereof
10/01/2014EP2784155A1 Adenovirus producing novel cell line and the use thereof
10/01/2014EP2784153A1 Method for culturing pluripotent stem cell
10/01/2014EP2784087A1 Recombinant baculovirus and use thereof
10/01/2014EP2784084A1 IL-17 A/F heterologous polypeptides and therapeutics uses thereof
10/01/2014EP2784080A1 Peptide-hinge-free flexible antibody-like molecule
10/01/2014EP2783005A1 Recombinant serotype 5 (ac]5) adenoviral vectors
10/01/2014EP2783004A1 Diterpene synthases and method for producing diterpenoids
10/01/2014EP2783003A1 Plants having enhanced yield-related traits and method for making the same
10/01/2014EP2783002A1 Plants having enhanced yield-related traits and method for making the same
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 4023